These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38417698)
1. The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases. Zhang Y; Liu Y; Huo W; He L; Li B; Wang H; Meng F; Duan C; Zhou B; Wu J; Chen R; Xing J; Wan Y Am J Pathol; 2024 Jun; 194(6):879-893. PubMed ID: 38417698 [TBL] [Abstract][Full Text] [Related]
2. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice. Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527 [TBL] [Abstract][Full Text] [Related]
4. Non-coding RNA crosstalk with nuclear receptors in liver disease. Wu J; Nagy LE; Liangpunsakul S; Wang L Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166083. PubMed ID: 33497819 [TBL] [Abstract][Full Text] [Related]
5. Prominin-1-expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury. Fenlon M; Short C; Xu J; Malkoff N; Mahdi E; Hough M; Glazier A; Lee C; Asahina K; Wang KS Physiol Rep; 2020 Jul; 8(14):e14508. PubMed ID: 32686913 [TBL] [Abstract][Full Text] [Related]
6. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases. Yang Z; Zhang T; Han S; Kusumanchi P; Huda N; Jiang Y; Liangpunsakul S Transl Res; 2021 Apr; 230():139-150. PubMed ID: 33227504 [TBL] [Abstract][Full Text] [Related]
8. Zebrafish as a Model to Study Cholestatic Liver Diseases. Pham DH; Yin C Methods Mol Biol; 2019; 1981():273-289. PubMed ID: 31016661 [TBL] [Abstract][Full Text] [Related]
9. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Li Y; Tang R; Leung PSC; Gershwin ME; Ma X Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease. Shi Q; Yuan X; Zeng Y; Wang J; Zhang Y; Xue C; Li L Nutrients; 2023 May; 15(10):. PubMed ID: 37242293 [TBL] [Abstract][Full Text] [Related]
11. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis. Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay. Zhang L; Yang Z; Trottier J; Barbier O; Wang L Hepatology; 2017 Feb; 65(2):604-615. PubMed ID: 27770549 [TBL] [Abstract][Full Text] [Related]
14. Linking long noncoding RNA to control bile acid signaling and cholestatic liver fibrosis. Chiang JYL Hepatology; 2017 Oct; 66(4):1032-1035. PubMed ID: 28543964 [No Abstract] [Full Text] [Related]
15. [Diagnosis of cholestatic disorders]. Geier A; Gartung C; Dietrich CG; Lammert F; Wasmuth HE; Matern S Med Klin (Munich); 2003 Sep; 98(9):499-509. PubMed ID: 14551707 [TBL] [Abstract][Full Text] [Related]
16. Effect of drug transporter pharmacogenetics on cholestasis. Dietrich CG; Geier A Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651 [TBL] [Abstract][Full Text] [Related]
17. MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis. Song Y; Tran M; Wang L; Shin DJ; Wu J Lab Invest; 2022 May; 102(5):485-493. PubMed ID: 34880414 [TBL] [Abstract][Full Text] [Related]